Bharat Biotech likely to launch Covaxin in second quarter next year

“The trial to be conducted in 25 to 30 sites across 13-14 states will provide two doses each for the…

Read More »

PMO confirms big reason why Coronavirus vaccine in India may not be delayed

As per the statement, the country’s top clinical body- ICMR and Department of Biotechnology have conducted two studies on Genome…

Read More »
Back to top button